Beam Therapeutics (NASDAQ:BEAM) outlined a new liver-targeted development program for phenylketonuria (PKU) and announced a large, non-dilutive financing tied to its sickle cell disease launch plans ...
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, ...
Beam Therapeutics’ experimental gene-editing therapy for sickle cell disease now has its first cut of patient data showing signs of treating the rare blood disorder in a way that could differentiate ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (BEAM) (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...
YORK, Pa. — A program in York brings community leaders and mentors together with students. The Boys Empowerment and Mentorship program, or BEAM, shares lessons with business leaders on the journey ...
ConnectiCare has made a donation of “more than 80 boxes of pads, tampons, and other period supplies to The Diaper Bank of Connecticut’s (CT) Beam program,” according to a statement. “Everyone deserves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results